News Channels

22 Dec 2020 Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate RNA Splicing for Serious Diseases
22 Dec 2020 Update on SOURCE Phase III trial for tezepelumab in patients with severe, oral corticosteroid-dependent asthma
22 Dec 2020 Vertex Announces FDA Approvals of TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) and KALYDECO® (ivacaftor) for Us...
22 Dec 2020 Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
22 Dec 2020 The European Commission Grants Marketing Authorization for PLEGRIDY® (peginterferon beta-1a) Intramuscular Administration for Relapsing-Remitting Multiple Sclerosis
22 Dec 2020 BioCryst Announces Positive Phase 1 Results with BCX9250, an Oral ALK-2 Inhibitor for Treatment of Fibrodysplasia Ossificans Progressiva
22 Dec 2020 BioInvent and Transgene receive CTA approval for Phase l/lla trial of oncolytic virus BT-001 in solid tumors
22 Dec 2020 Genentech’s Faricimab Meets Primary Endpoint and Shows Strong Durability Across Two Global Phase III Studies for Diabetic Macular Edema, a Leading Cause of Blindness
21 Dec 2020 Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
20 Dec 2020 Novartis receives complete response letter from U.S. FDA for inclisiran
20 Dec 2020 FDA Approves First Adjuvant Therapy for Most Common Type of Lung Cancer
20 Dec 2020 U.S. FDA Approves Supplemental New Drug Application for Takeda’s ICLUSIG® (ponatinib) for Adult Patients with Resistant or Intolerant Chronic-Phase CML
19 Dec 2020 Karyopharm Announces FDA Approval of XPOVIO® (Selinexor) as a Treatment for Patients with Multiple Myeloma After At Least One Prior Therapy
19 Dec 2020 Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer
19 Dec 2020 Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.
18 Dec 2020 New SARS-CoV-2 Neutralizing Antibody enters Clinical Phase
18 Dec 2020 Janux Therapeutics Announces Collaboration with Merck to Develop Novel Drug Candidates for Immuno-Oncology using T Cell Engager (TRACTr) Technology
18 Dec 2020 MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule
18 Dec 2020 Metacrine Reports Positive Results from Phase 1 Trial of MET642
18 Dec 2020 Otonomy Reports Positive Top-Line Results from Phase 1/2 Clinical Trial of OTO-413 in Patients with Hearing Loss

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top